Simple biological systems for assessing the activity of superoxide dismutase mimics

Antioxidants and Redox Signaling

Volumn 20, Issue 15, 2014, Pages 2416-2436

  Tovmasyan, Artak ^a   Reboucas, Julio S ^b   Benov, Ludmil ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE; PORPHYRIN; PORPHYRIN DERIVATIVE; SUPEROXIDE DISMUTASE; METALLOPORPHYRIN;

BACTERIAL GROWTH; BIOLOGICAL ACTIVITY; BIOLOGY; CATALYSIS; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CULTURE MEDIUM; ENZYME ACTIVITY; ESCHERICHIA COLI; GROWTH CURVE; LIPOPHILICITY; LIQUID CULTURE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; SCREENING; ANIMAL; CHEMICAL PHENOMENA; CHEMISTRY; ENZYME ACTIVATION; GENETICS; HUMAN; METABOLISM; MOLECULAR MIMICRY; MUTATION;

ANIMALS; CATALYSIS; ENZYME ACTIVATION; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; METALLOPORPHYRINS; MOLECULAR MIMICRY; MUTATION; SUPEROXIDE DISMUTASE;

EID: 84899721306     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5576     Document Type: Review

References (131)

1. Al-Maghrebi M, Fridovich I, and Benov L. Manganese supplementation relieves the phenotypic deficits seen in superoxide-dismutase-null Escherichia coli. Arch Biochem Biophys 402: 104-109, 2002.
2. Al-Mutairi DA, Craik JD, Batinic-Haberle I, and Benov LT. Photosensitizing action of isomeric zinc N-methylpyridylporphyrins in human carcinoma cells. Free Radic Res 40: 477-483, 2006.
3. Al-Mutairi DA, Craik JD, Batinic-Haberle I, and Benov LT. Inactivation of metabolic enzymes by photo-treatment with zinc meta N-methylpyridylporphyrin. Biochim Biophys Acta 1770: 1520-1527, 2007.
4. Al-Mutairi DA, Craik JD, Batinic-Haberle I, and Benov LT. Induction of oxidative cell damage by photo-treatment with zinc N-methylpyridylporphyrin. Free Radic Res 41: 89-96, 2007.
5. Anjem A, and Imlay JA. Mononuclear iron enzymes are primary targets of hydrogen peroxide stress. J Biol Chem 287: 15544-15556, 2012.
6. Archibald FS, and Fridovich I. Manganese and defenses against oxygen toxicity in Lactobacillus plantarum. J Bacteriol 145: 442-451, 1981.
7. Archibald FS, and Fridovich I. The scavenging of superoxide radical by manganous complexes: in vitro. Arch Biochem Biophys 214: 452-463, 1982.
8. Bafana A, Dutt S, Kumar A, Kumar S, and Ahuja PS. The basic and applied aspects of superoxide dismutase. J Mol Catal B: Enzymatic 68: 129-138, 2011.
9. Bafana A, Dutt S, Kumar S, and Ahuja PS. Superoxide dismutase: an industrial perspective. Crit Rev Biotechnol 31: 65-76, 2011.
10. Barnese K, Gralla E, Valentine J, and Cabelli DE. Biologically relevant mechanism for catalytic superoxide removal by simple manganese compounds. Proc Natl Acad Sci U S A 109: 6892-6897, 2012.
11. Batinic-Haberle I, Reboucas JS, Benov L, and Spasojevi I. Chemistry, biology and medical effects of water soluble metalloporphyrins. In: Handbook of Porphyrin Science, edited by Kadish KM, Smith KM, and Guillard R. Singapore: World Scientific, 2011, pp. 291-393.
12. Batinic-Haberle I, Benov L, Spasojevic I, and Fridovich I. The ortho effect makes manganese(III) meso-tetrakis(Nmethylpyridinium- 2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J Biol Chem 273: 24521-24528, 1998.
13. Batinic-Haberle I, Cuzzocrea S, Rebouças JS, Ferrer-Sueta G, Mazzon E, Di Paola R, Radi R, Spasojevic I, Benov L, and Salvemini D. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy. Free Radic Biol Med 46: 192-201, 2009.
14. Batinic-Haberle I, Liochev SI, Spasojevic I, and Fridovich I. A potent superoxide dismutase mimic: manganese betaoctabromo-meso-tetrakis-(N- methylpyridinium-4-yl) porphyrin. Arch Biochem Biophys 343: 225-233, 1997.
15. Batinić-Haberle I, Rajić Z, and Benov L. A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon. Anticancer Agents Med Chem 11: 329-340, 2011.
16. Batinic-Haberle I, Rajic Z, Tovmasyan A, Reboucas JS, Ye X, Leong KW, Dewhirst MW, Vujaskovic Z, Benov L, and Spasojevic I. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med 51: 1035-1053, 2011.
17. Batinić-Haberle I, Rebouças JS, and Spasojević I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 13: 877-918, 2010.
18. Batinic-Haberle I, Spasojevic I, and Fridovich I. Tetrahydrobiopterin rapidly reduces the SOD mimic Mn(III) ortho-tetrakis(N-ethylpyridinium-2-yl) porphyrin. Free Radic Biol Med 37: 367-374, 2004.
19. Batinic-Haberle I, Spasojevic I, Hambright P, Benov L, Cmmbliss AL, and Fridovich I. Relationship among redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vivo and in vitro superoxide dismutating activities of manganese(III) and iron(III) water-soluble porphyrins. Inorg Chem 38: 4011-4022, 1999.
20. •- dismutation: Mn(III) orthomethoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins. Dalton Trans 1696-1702, 2004.
21. Batinic-Haberle I, Spasojevic I, Tse HM, Tovmasyan A, Rajic Z, St Clair DK, Vujaskovic Z, Dewhirst MW, and Piganelli JD. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Amino Acids 42: 95-113, 2012.
22. Batinic-Haberle I, Tovmasyan A, Roberts ERH, Vujaskovic Z, Leong KW, and Spasojevic I. SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal 20: 2372-2415, 2014.
23. Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis 26: 1-13, 2007.
24. Benov L, Batinic-Haberle I, Spasojevic I, and Fridovich I. Isomeric N-alkylpyridylporphyrins and their Zn(II) complexes: inactive as SOD mimics but powerful photosensitizers. Arch Biochem Biophys 402: 159-165, 2002.
25. Benov L, Chang LY, Day B, and Fridovich I. Copper, zinc superoxide dismutase in Escherichia coli periplasmic localization. Arch Biochem Biophys 319: 508-511, 1995.
26. Benov L, Craik J, and Batinic-Haberle I. The potential of Zn(II) N-alkylpyridylporphyrins for anticancer therapy. Anticancer Agents Med Chem 11: 233-241, 2011.
27. Benov L, Craik J, and Batinic-Haberle I. Protein damage by photo-activated Zn(II) N-alkylpyridylporphyrins. Amino Acids 42: 117-128, 2012.
28. Benov L, and Fridovich I. Superoxide dismutase protects against aerobic heat shock in Escherichia coli. J Bacteriol 177: 3344-3346, 1995.
29. Benov L, and Fridovich I. The rate of adaptive mutagenesis in Escherichia coli is enhanced by oxygen (superoxide). Mutat Res 357: 231-236, 1996.
30. Benov L, and Fridovich I. Why superoxide imposes an aromatic amino acid auxotrophy on Escherichia coli: the transketolase connection. J Biol Chem 274: 4202-4206, 1999.
31. Benov L, Kredich NM, and Fridovich I. The mechanism of the auxotrophy for sulfur-containing amino acids imposed upon Escherichia coli by superoxide. J Biol Chem 271: 21037-21040, 1996.
32. Benov LT, and Fridovich I. Escherichia coli expresses a copper- and zinc-containing superoxide dismutase. J Biol Chem 269: 25310-25314, 1994.
33. Bernard AS, Giroud C, Ching HYV, Meunier A, Ambike V, Amatore C, Collignon MG, Lemaître F, and Policar C. Evaluation of the anti-oxidant properties of a SOD-mimic Mn-complex in activated macrophages. Dalton Trans 41: 6399-6403, 2012.
34. Bilinski T, Krawiec Z, Liczmanski A, and Litwinska J. Is hydroxyl radical generated by the Fenton reaction in vivo? Biochem Biophys Res Commun 130: 533-539, 1985.
35. Carlioz A, and Touati D. Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life? EMBO J 5: 623-630, 1986.
36. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DS, Drisko J, and Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A 105: 11105-11109, 2008.
37. Chiang SM, and Schellhorn HE. Regulators of oxidative stress response genes in Escherichia coli and their functional conservation in bacteria. Arch Biochem Biophys 525: 161-169, 2012.
38. Contestabile A. Amyotrophic lateral sclerosis: from research to therapeutic attempts and therapeutic perspectives. Curr Med Chem 18: 5655-5665, 2011.
39. Czapski G, and Goldstein S. The uniqueness of superoxide dismutase (SOD)-why cannot most copper compounds substitute SOD in vivo? Free Radic Res Commun 4: 225-229, 1988.
40. Czapski G, and Goldstein S. Requirements for SOD mimics operating in vitro to work also in vivo. Free Radic Res Commun 12-13 Pt 1: 167-171, 1991.
41. De Freitas JM, Liba A, Meneghini R, Valentine JS, and Gralla EB. Yeast lacking Cu-Zn superoxide dismutase show altered iron homeostasis: role of oxidative stress in iron metabolism. J Biol Chem 275: 11645-11649, 2000.
42. DeFreitas-Silva G, Reboucas JS, Spasojevic I, Benov L, Idemori YM, and Batinic-Haberle I. SOD-like activity of Mn(II) β-octabromo-meso-tetrakis(N- methylpyridinium-3- yl)porphyrin equals that of the enzyme itself. Arch Biochem Biophys 477: 105-112, 2008.
43. Delmastro-Greenwood MM, Tse HM, and Piganelli JD. Effects of metalloporphyrins on reducing inflammation and autoimmunity. Antioxid Redox Signal 20: 2465-2477, 2014.
44. Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Ha°rdemark HG, and Rodichok L. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke 39: 1751-1758, 2008.
45. Doctrow SR, Baudry M, Huffman K, Malfroy B, and Melov S. Salen manganese complexes: multifunctional catalytic antioxidants protective in models for neurodegenerative diseases of aging in medicinal inorganic chemistry. In: American Chemical Society Symposium Series 903, ACS, edited by Sessler J, Doctrow SR, McMurry T, and Lippard S. Oxford University Press, 2005, pp. 319-347.
46. Du J, Martin SM, Levine M, Wagner BA, Buettner GR, Wang S-h, Taghiyev AF, Du C, Knudson CM, and Cullen JJ. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res 16: 509-520, 2010.
47. Edsmyr F, and Menander-Huber KB. Orgotein efficacy in ameliorating side effects due to radiation therapy. Eur J Rheumatol Inflamm 4: 228-236, 1981.
48. Evans MK, Tovmasyan A, Batinic-Haberle I, and Devi GR. Mn porphyrin in combination with ascorbate acts as a prooxidant and mediates caspase-independent cancer cell death. Free Radic Biol Med, 2013 (in press).
49. Farr SB, D'Ari R, and Touati D. Oxygen-dependent mutagenesis in Escherichia coli lacking superoxide dismutase. Proc Natl Acad Sci U S A 83: 8268-8272, 1986.
50. Faulkner KM, Liochev SI, and Fridovich I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J Biol Chem 269: 23471-23476, 1994.
51. Figge FH, Weiland GS, and Manganiello LO. Cancer detection and therapy: affinity of neoplastic, embryonic, and traumatized tissues for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 68: 640, 1948.
52. Floyd RA, Castro Faria Neto HC, Zimmerman GA, Hensley K, and Towner RA. Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines. Free Radic Biol Med 62: 145-156, 2013.
53. Floyd RA, Chandru HK, He T, and Towner R. Anti-cancer activity of nitrones and observations on mechanism of action. Anticancer Agents Med Chem 11: 373-379, 2011.
54. Floyd RA, Towner RA, He T, Hensley K, and Maples KR. Translational research involving oxidative stress and diseases of aging. Free Radic Biol Med 51: 931-941, 2011.
55. Fridovich I. Oxygen toxicity: a radical explanation. J Exp Biol 201: 1203-1209, 1998.
56. Fridovich I. Oxygen: how do we stand it? Med Princ Pract 22: 131-137, 2013.
57. Genovese T, Mazzon E, Esposito E, Di Paola R, Murthy K, Neville L, Bramanti P, and Cuzzocrea S. Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww- 85, in a mouse model of spinal cord injury. Free Radic Res 43: 631-645, 2009.
58. Giles SS, Batinic-Haberle I, Perfect JR, and Cox GM. Cryptococcus neoformans mitochondrial superoxide dismutase: an essential link between antioxidant function and hightemperature growth. Eukaryot Cell 4: 46-54, 2005.
59. Gort AS, and Imlay JA. Balance between endogenous superoxide stress and antioxidant defenses. J Bacteriol 180: 1402-1410, 1998.
60. Gralla EB, and Valentine JS. Null mutants of Saccharomyces cerevisiae Cu, Zn superoxide dismutase: characterization and spontaneous mutation rates. J Bacteriol 173: 5918-5920, 1991.
61. Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L, and Miller Jr WH. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol 19: 1969-1974, 2008.
62. Imlay JA. Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem 77: 755-776, 2008.
63. Imlay JA, and Fridovich I. Isolation and genetic analysis of a mutation that suppresses the auxotrophies of superoxide dismutase-deficient Escherichia coli K12. Mol Gen Genet 228: 410-416, 1991.
64. Imlay JA, and Fridovich I. Suppression of oxidative envelope damage by pseudoreversion of a superoxide dismutase-deficient mutant of Escherichia coli. J Bacteriol 174: 953-961, 1992.
65. Keaney M, Matthijssens F, Sharpe M, Vanfleteren J, and Gems D. Superoxide dismutase mimetics elevate superoxide dismutase activity in vivo but do not retard aging in the nematode Caenorhabditis elegans. Free Radic Biol Med 37: 239-250, 2004.
66. Kos I, Benov L, Spasojević I, Rebouças JS, and Batinić-Haberle I. High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli. J Med Chem 52: 7868-7872, 2009.
67. Kos I, Rebouças JS, DeFreitas-Silva G, Salvemini D, Vujaskovic Z, Dewhirst MW, Spasojević I, and Batinić-Haberle I. Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins. Free Radic Biol Med 47: 72-78, 2009.
68. Lange M, Szabo C, Enkhbaatar P, Connelly R, Horvath E, Hamahata A, Cox RA, Esechie A, Nakano Y, Traber LD, Herndon DN, and Traber DL. Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury. Am J Physiol Lung Cell Mol Physiol 300: L167-L175, 2011.
69. Lapinskas PJ, Cunningham KW, Xiu Fen L, Fink GR, and Culotta VC. Mutations in PMR1 suppress oxidative damage in yeast cells lacking superoxide dismutase. Mol Cell Biol 15: 1382-1388, 1995.
70. Lin SJ, and Culotta VC. The ATX1 gene of Saccharomyces cerevisiae encodes a small metal homeostasis factor that protects cells against reactive oxygen toxicity. Proc Natl Acad Sci U S A 92: 3784-3788, 1995.
71. Liochev SI. The mechanism of "Fenton-like" reactions and their importance for biological systems: a biologist's view. Met Ions Biol Syst 36: 1-39, 1999.
72. Lipson RL, Baldes EJ, and Gray MJ. Hematoporphyrin derivative for detection and management of cancer. Cancer 20: 2255-2257, 1967.
73. Liu D, Shan Y, Valluru L, and Bao F. Mn (III) tetrakis (4- benzoic acid) porphyrin scavenges reactive species, reduces oxidative stress, and improves functional recovery after experimental spinal cord injury in rats: comparison with methylprednisolone. BMC Neurosci 14: 23, 2013.
74. Liu XF, and Culotta VC. The requirement for yeast superoxide dismutase is bypassed through mutations in BSD2, a novel metal homeostasis gene. Mol Cell Biol 14: 7037-7045, 1994.
75. Longo VD, Gralla EB, and Valentine JS. Superoxide dismutase activity is essential for stationary phase survival in Saccharomyces cerevisiae: mitochondrial production of toxic oxygen species in vivo. J Biol Chem 271: 12275-12280, 1996.
76. Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, Grotta JC, Ashwood TJ, Hardemark HG, Svensson HH, Rodichok L, Wasiewski WW, and A° hlberg G. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT trial. Stroke 38: 2262-2269, 2007.
77. Macomber L, Rensing C, and Imlay JA. Intracellular copper does not catalyze the formation of oxidative DNA damage in Escherichia coli. J Bacteriol 189: 1616-1626, 2007.
78. Matthijssens F, Back P, Braeckman BP, and Vanfleteren JR. Prooxidant activity of the superoxide dismutase (SOD)- mimetic EUK-8 in proliferating and growth-arrested Escherichia coli cells. Free Radic Biol Med 45: 708-715, 2008.
79. Maybauer DM, Maybauer MO, Szabo C, Cox RA, Westphal M, Kiss L, Horvath EM, Traber LD, Hawkins HK, Salzman AL, Southan GJ, Herndon DN, and Traber DL. The peroxynitrite catalyst WW-85 improves pulmonary function in ovine septic shock. Shock 35: 148-155, 2011.
80. Maybauer DM, Maybauer MO, Szabo C, Westphal M, Traber LD, Salzman AL, Herndon DN, and Traber DL. The peroxynitrite catalyst WW-85 improves microcirculation in ovine smoke inhalation injury and septic shock. Burns 37: 842-850, 2011.
81. Menander-Huber KB. Orgotein in the treatment of rheumatoid arthritis. Eur J Rheumatol Inflamm 4: 201-211, 1981.
82. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vujaskovic Z, St Clair D, and Batinic-Haberle I. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta 1822: 794-814, 2012.
83. Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, Pillai MV, Newberg AB, Deshmukh S, and Levine M. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS ONE 7: e29794, 2012.
84. Moriscot C, Candel S, Sauret V, Kerr-Conte J, Richard MJ, Favrot MC, and Benhamou PY. MnTMPyP, a metalloporphyrin-based superoxide dismutase/catalase mimetic, protects INS-1 cells and human pancreatic islets from an in vitro oxidative challenge. Diabetes Metab 33: 44-53, 2007.
85. Munroe W, Kingsley C, Durazo A, Gralla EB, Imlay JA, Srinivasan C, and Valentine JS. Only one of a wide assortment of manganese-containing SOD mimicking compounds rescues the slow aerobic growth phenotypes of both Escherichia coli and Saccharomyces cerevisiae strains lacking superoxide dismutase enzymes. J Inorg Biochem 101: 1875-1882, 2007.
86. Muscoli C, Cuzzocrea S, Riley DP, Zweier JL, Thiemermann C, Wang ZQ, and Salvemini D. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol 140: 445-460, 2003.
87. Natvig DO, Imlay K, Touati D, and Hallewell RA. Human copper-zinc superoxide dismutase complements superoxide dismutase-deficient Escherichia coli mutants. J Biol Chem 262: 14697-14701, 1987.
88. Okado-Matsumoto A, Batinic-Haberle I, and Fridovich I. Complementation of SOD-deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase activity. Free Radic Biol Med 37: 401-410, 2004.
89. Pasternack RF, and Halliwell B. Superoxide dismutase activities of an iron porphyrin and other iron complexes. J Am Chem Soc 101: 1026-1031, 1979.
90. Peleg M, and Corradini MG. Microbial growth curves: what the models tell us and what they cannot. Crit Rev Food Sci Nutr 51: 917-945, 2011.
91. Pieper GM, Nilakantan V, Chen M, Zhou J, Khanna AK, Henderson JD, Jr., Johnson CP, Roza AM, and Szabo C. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants. J Pharmacol Exp Ther 314: 53-60, 2005.
92. Rajic Z, Benov L, Kos I, Tovmasyan A, and Batinic-Haberle I. Cationic Mn porphyrins change their action from anti- to pro-oxidative in the presence of cellular reductants: relevance to understanding the beneficial therapeutic effects of SOD mimics in vivo. Free Radic Biol Med 49: S194-S194, 2010.
93. Rajic Z, Tovmasyan A, Spasojevic I, Sheng H, Lu M, Li AM, Gralla EB, Warner DS, Benov L, and Batinic-Haberle I. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity. Free Radic Biol Med 52: 1828-1834, 2012.
94. Ravindranath SD, and Fridovich I. Isolation and characterization of a manganese-containing superoxide dismutase from yeast. J Biol Chem 250: 6107-6112, 1975.
95. Rawal M, Schroeder SR, Wagner BA, Du J, Buettner GR, and Cullen JJ. Potential of manganoporphyrins to enhance the efficacy of pharmacological ascorbate in the treatment of pancreatic cancer. Free Radic Biol Med 53: S115-S115, 2012.
96. Rebouças JS, DeFreitas-Silva G, Spasojevic I, Idemori YM, Benov L, and Batinic-Haberle I. Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier. Free Radic Biol Med 45: 201-210, 2008.
97. Reboucas JS, Kos I, Vujaskovic Z, and Batinic-Haberle I. Determination of residual manganese in Mn porphyrinbased superoxide dismutase (SOD) and peroxynitrite reductase mimics. J Pharm Biomed Anal 50: 1088-1091, 2009.
98. Reboucas JS, Spasojevic I, and Batinic-Haberle I. Pure manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin (MnTBAP) is not a superoxide dismutase mimic in aqueous systems: a case of structure-activity relationship as a watchdog mechanism in experimental therapeutics and biology. J Biol Inorg Chem 13: 289-302, 2008.
99. Reboucas JS, Spasojevic I, and Batinic-Haberle I. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes. J Pharm Biomed Anal 48: 1046-1049, 2008.
100. Reboucas JS, Spasojevic I, Tjahjono DH, Richaud A, Mendez F, Benov L, and Batinic-Haberle I. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution. Dalton Trans 1233-1242, 2008.
101. Reddan JR, Giblin FJ, Sevilla M, Padgaonkar V, Dziedzic DC, Leverenz VR, Misra IC, Chang JS, and Pena JT. Propyl gallate is a superoxide dismutase mimic and protects cultured lens epithelial cells from H2O2 insult. Exp Eye Res 76: 49-59, 2003.
102. Riley DP, Lennon PJ, Neumann WL, and Weiss RH. Toward the rational design of superoxide dismutase mimics: mechanistic studies for the elucidation of substituent effects on the catalytic activity of macrocyclic manganese(II) complexes. J Am Chem Soc 119: 6522-6528, 1997.
103. Rosenthal RA, Fish B, Hill RP, Huffman KD, Lazarova Z, Mahmood J, Medhora M, Molthen R, Moulder JE, Sonis ST, Tofilon PJ, and Doctrow SR. Salen Mn complexes mitigate radiation injury in normal tissues. Anticancer Agents Med Chem 11: 359-372, 2011.
104. Rosenthal RA, Huffman KD, Fisette LW, Damphousse CA, Callaway WB, Malfroy B, and Doctrow SR. Orally available Mn porphyrins with superoxide dismutase and catalase activities. J Biol Inorg Chem 14: 979-991, 2009.
105. Sambrook J, Fritsch EF, and Maniatis T. Molecular Cloning. New York: Cold Spring Harbor Laboratory Press, 1989.
106. Sanchez RJ, Srinivasan C, Munroe WH, Wallace MA, Martins J, Kao TY, Le K, Gralla EB, and Valentine JS. Exogenous manganous ion at millimolar levels rescues all known dioxygen-sensitive phenotypes of yeast lacking CuZnSOD. J Biol Inorg Chem 10: 913-923, 2005.
107. Schreier S, Malheiros SVP, and De Paula E. Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. Biochim Biophys Acta 1508: 210-234, 2000.
108. Sheng H, Chaparro RE, Sasaki T, Izutsu M, Pearlstein RD, Tovmasyan A, and Warner DS. Metalloporphyrins as therapeutic catalytic oxidoreductants in central nervous system disorders. Antioxid Redox Signal 20: 2437-2464, 2014.
109. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, and Emeribe U. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357: 562-571, 2007.
110. Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, and Mitchell JB. The chemistry and biology of nitroxide compounds. Free Radic Biol Med 42: 1632-1650, 2007.
111. Spasojevic I, Kos I, Benov LT, Rajic Z, Fels D, Dedeugd C, Ye X, Vujaskovic Z, Reboucas JS, Leong KW, Dewhirst MW, and Batinic-Haberle I. Bioavailability of metalloporphyrin-based SOD mimics is greatly influenced by a single charge residing on a Mn site. Free Radic Res 45: 188-200, 2011.
112. Spasojevic I, Li A, Tovmasyan A, Rajic Z, Salvemini D, St Clair D, Valentine JS, Vujaskovic Z, Gralla EB, and Batinic-Haberle I. Accumulation of porphyrin-based SOD mimics in mitochondria is proportional to their lipophilicity: S-cerevisiae study of ortho Mn(III) N-alkylpyridylporphyrins. Free Radic Biol Med 49: S199-S199, 2010.
113. Stojiljkovic I, Evavold BD, and Kumar V. Antimicrobial properties of porphyrins. Expert Opin Investig Drugs 10: 309-320, 2001.
114. Strain J, Lorenz CR, Bode J, Garland S, Smolen GA, Ta DT, Vickery LE, and Culotta VC. Suppressors of superoxide dismutase (SOD1) deficiency in Saccharomyces cerevisiae: identification of proteins predicted to mediate iron-sulfur cluster assembly. J Biol Chem 273: 31138-31144, 1998.
115. Szabo C, Mabley JG, Moeller SM, Shimanovich R, Pacher P, Virag L, Soriano FG, Van Duzer JH, Williams W, Salzman AL, and Groves JT. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med 8: 571-580, 2002.
116. Szabo G, Loganathan S, Merkely B, Groves JT, Karck M, Szabo C, and Radovits T. Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation. J Thorac Cardiovasc Surg 143: 1443-1449, 2012.
117. Tian J, Peehl DM, and Knox SJ. Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through Fenton chemistry. Cancer Biother Radiopharm 25: 439-448, 2010.
118. Touati D. Molecular genetics of superoxide dismutases. Free Radic Biol Med 5: 393-402, 1988.
119. Touati D. The molecular genetics of superoxide dismutase in E. coli. Free Radic Res Commun 12-13 Pt 1: 379-382, 1991.
120. Tovmasyan A, Sheng H, Weitner T, Arulpragasam A, Lu M, Warner DS, Vujaskovic Z, Spasojevic I, and Batinic-Haberle I. Design, mechanism of action, bioavailability and therapeutic effects of Mn porphyrin-based redox modulators. Med Princ Pract 22: 103-130, 2013.
121. Tovmasyan A, Weitner T, Roberts E, Jaramillo M, Spasojevic I, Leong KW, Tome M, Benov L, and Batinic-Haberle I. Understanding differences in mechanisms of action of Fe vs. Mn porphyrins: comparison of their reactivities towards cellular reductants and reactive species. Free Radic Biol Med 53: S120, 2012.
122. Tovmasyan A, Weitner T, Sheng H, Lu M, Rajic Z, Warner DS, Spasojevic I, Reboucas JS, Benov L, and Batinic-Haberle I. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology. Inorg Chem 52: 5677-5691, 2013.
123. Tovmasyan AG, Rajic Z, Spasojevic I, Reboucas JS, Chen X, Salvemini D, Sheng H, Warner DS, Benov L, and Batinic-Haberle I. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins: synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(iii) N-methoxyalkylpyridylporphyrins. Dalton Trans 40: 4111-4121, 2011.
124. Van Loon APGM, Pesold-Hurt B, and Schatz G. A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. Proc Natl Acad Sci U S A 83: 3820-3824, 1986.
125. Wallace MA, Liou LL, Martins J, Clement MHS, Bailey S, Longo VD, Valentine JS, and Gralla EB. Superoxide inhibits 4Fe-4S cluster enzymes involved in amino acid biosynthesis: cross-compartment protection by CuZn-superoxide dismutase. J Biol Chem 279: 32055-32062, 2004.
126. Weitner T, Kos I, Sheng H, Tovmasyan A, Reboucas JS, Fan P, Warner DS, Vujaskovic Z, Batinic-Haberle I, and Spasojevic I. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP(5+) and MnTnHex-2-PyP(5+). Free Radic Biol Med 58: 73-80, 2013.
127. Welsh JL, Wagner BA, Van'T Erve TJ, Zehr PS, Berg DJ, Halfdanarson TR, Yee NS, Bodeker KL, Du J, Roberts II LJ, Drisko J, Levine M, Buettner GR, and Cullen JJ. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol 71: 765-775, 2013.
128. Wu L, Shan Y, and Liu D. Stability, disposition, and penetration of catalytic antioxidants Mn-porphyrin and Mnsalen and of methylprednisolone in spinal cord injury. Cent Nerv Syst Agents Med Chem 12: 122-130, 2012.
129. Xiu Fen L, Elashvili I, Gralla EB, Valentine JS, Lapinskas P, and Culotta VC. Yeast lacking superoxide dismutase: isolation of genetic suppressors. J Biol Chem 267: 18298-18302, 1992.
130. Ye X, Fels D, Tovmasyan A, Aird KM, Dedeugd C, Allensworth JL, Kos I, Park W, Spasojevic I, Devi GR, Dewhirst MW, Leong KW, and Batinic-Haberle I. Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate. Free Radic Res 45: 1289-1306, 2011.
131. Zyracka E, Zadrag R, Kozioł S, Krzepiłko A, Bartosz G, and Biliń ski T. Yeast as a biosensor for antioxidants: simple growth tests employing a Saccharomyces cerevisiae mutant defective in superoxide dismutase. Acta Biochim Pol 52: 679-684, 2005.